{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for beta root_names_name in Any Name (approximate match)
Status:
Investigational
Source:
NCT03700294: Phase 1 Interventional Terminated Advanced Solid Tumors
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04097821: Phase 1/Phase 2 Interventional Completed Myelofibrosis
(2019)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03188666: Phase 2 Interventional Completed Fibrodysplasia Ossificans Progressiva
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:pegdarbepoetin beta [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03631706: Phase 3 Interventional Completed Non-small Cell Lung Cancer
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03858634: Phase 2 Interventional Completed Chronic Idiopathic Urticaria
(2019)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:sampeginterferon beta-1a [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02356978: Not Applicable Interventional Unknown status Crigler Najjar Syndrome
(2014)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00411723: Phase 1 Interventional Unknown status Multiple Sclerosis, Chronic Progressive
(2006)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02384538: Phase 2 Interventional Completed Erosive Hand Osteoarthritis
(2015)
Source URL:
Class:
PROTEIN